Exact Mass: 322.0202

Exact Mass Matches: 322.0202

Found 57 metabolites which its exact mass value is equals to given mass value 322.0202, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Chloramphenicol

D-(-)-2,2-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenylethyl)acetamide

C11H12Cl2N2O5 (322.0123)


An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106) G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AA - Antibiotics D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use > D10AF - Antiinfectives for treatment of acne D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01B - Amphenicols > J01BA - Amphenicols S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3070 C254 - Anti-Infective Agent > C258 - Antibiotic C784 - Protein Synthesis Inhibitor KEIO_ID C057; [MS3] KO008919 KEIO_ID C057; [MS2] KO008918 KEIO_ID C057

   

Sulprofos

Ethoxy-(4-methylsulphanylphenoxy)-propylsulphanyl-sulphanylidene-$l^{5}-phosphane

C12H19O2PS3 (322.0285)


C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor

   

Sulfotep

Diethoxy-[ethoxy(methoxymethyl)phosphinothioyl]oxy-sulfanylidene-lambda5-phosphane

C8H20O5P2S2 (322.0227)


C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor

   

Minodronic acid

Minodronic acid

C9H12N2O7P2 (322.012)


C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates Minodronic acid (YM-529) is a third-generation bisphosphonate that directly and indirectly prevents proliferation, induces apoptosis, and inhibits metastasis of various types of cancer cells. Minodronic acid (YM-529) is an antagonist of purinergic P2X2/3 receptors involved in pain[1][2].

   

Dextramycin

2,2-Dichloro-N-[1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]ethanimidate

C11H12Cl2N2O5 (322.0123)


   

Minodronic acid

(1-Hydroxy-2-(imidazo(1,2-a)-pyridin-3-yl)ethylidene)bisphosphonic acid monohydrate

C9H12N2O7P2 (322.012)


C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates Minodronic acid (YM-529) is a third-generation bisphosphonate that directly and indirectly prevents proliferation, induces apoptosis, and inhibits metastasis of various types of cancer cells. Minodronic acid (YM-529) is an antagonist of purinergic P2X2/3 receptors involved in pain[1][2].

   

Sulfotep

O,O-diethyl {[diethoxy(sulfanylidene)-λ⁵-phosphanyl]oxy}phosphonothioate

C8H20O5P2S2 (322.0227)


C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor

   

Trofosfamide

2-[bis(2-chloroethyl)amino]-3-(2-chloroethyl)-1,3,2lambda5-oxazaphosphinan-2-one

C9H18Cl3N2O2P (322.0171)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents > L01AA - Nitrogen mustard analogues D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D009676 - Noxae > D000477 - Alkylating Agents D009676 - Noxae > D009153 - Mutagens

   

cyanidin

1-benzopyrylium, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-, chloride (1:1)

C15H11ClO6 (322.0244)


See also: Bilberry (part of). Cyanidin Chloride (IdB 1027), a subclass of anthocyanin, displays antioxidant and anti-carcinogenesis properties. Cyanidin Chloride (IdB 1027) inhibits osteoclast formation, hydroxyapatite resorption, and receptor activator of NF-κB ligand (RANKL)-induced osteoclast marker gene expression[1]. Cyanidin Chloride (IdB 1027), a subclass of anthocyanin, displays antioxidant and anti-carcinogenesis properties. Cyanidin Chloride (IdB 1027) inhibits osteoclast formation, hydroxyapatite resorption, and receptor activator of NF-κB ligand (RANKL)-induced osteoclast marker gene expression[1].

   
   

ClC(C(C=C(C=CC=CC=CC(CC)C)O)=O)(Cl)Cl

ClC(C(C=C(C=CC=CC=CC(CC)C)O)=O)(Cl)Cl

C14H17Cl3O2 (322.0294)


   

6-(Sulfooxy)-9H-pyrido[3,4-b]indole-3-carboxylic acid 3-methyl ester

6-(Sulfooxy)-9H-pyrido[3,4-b]indole-3-carboxylic acid 3-methyl ester

C13H10N2O6S (322.026)


   

chloramphenicol

2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide

C11H12Cl2N2O5 (322.0123)


G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AA - Antibiotics D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use > D10AF - Antiinfectives for treatment of acne An organochlorine compound that is dichloro-substituted acetamide containing a nitrobenzene ring, an amide bond and two alcohol functions. D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01B - Amphenicols > J01BA - Amphenicols S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic C784 - Protein Synthesis Inhibitor CONFIDENCE standard compound; INTERNAL_ID 662; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3461; ORIGINAL_PRECURSOR_SCAN_NO 3459 CONFIDENCE standard compound; INTERNAL_ID 662; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3476; ORIGINAL_PRECURSOR_SCAN_NO 3473 CONFIDENCE standard compound; INTERNAL_ID 662; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3449; ORIGINAL_PRECURSOR_SCAN_NO 3445 CONFIDENCE standard compound; INTERNAL_ID 662; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3469; ORIGINAL_PRECURSOR_SCAN_NO 3467 CONFIDENCE standard compound; INTERNAL_ID 662; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3457; ORIGINAL_PRECURSOR_SCAN_NO 3455 CONFIDENCE standard compound; INTERNAL_ID 662; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3458; ORIGINAL_PRECURSOR_SCAN_NO 3457 Origin: Microbe, Propylene glycols, Nitrobenzenes CONFIDENCE standard compound; INTERNAL_ID 2306 CONFIDENCE standard compound; INTERNAL_ID 8318 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.577 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.575 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.573 CONFIDENCE standard compound; INTERNAL_ID 4073

   

Chloramphenicol_major

Chloramphenicol_major

C11H12Cl2N2O5 (322.0123)


   

2-CHLORO-N-(4-CHLORO-2-((HYDROXYIMINO)(PHENYL)METHYL)PHENYL)ACETAMIDE

2-CHLORO-N-(4-CHLORO-2-((HYDROXYIMINO)(PHENYL)METHYL)PHENYL)ACETAMIDE

C15H12Cl2N2O2 (322.0276)


   

methyl 4-(methylsulfonamidomethyl)-2-sulfamoylbenzoate

methyl 4-(methylsulfonamidomethyl)-2-sulfamoylbenzoate

C10H14N2O6S2 (322.0293)


   

Ethanone,1,1-(oxydi-4,1-phenylene)bis[2-chloro-

Ethanone,1,1-(oxydi-4,1-phenylene)bis[2-chloro-

C16H12Cl2O3 (322.0163)


   
   

3-(4-[(2,4-DICHLOROBENZYL)OXY]PHENYL)ACRYLIC ACID

3-(4-[(2,4-DICHLOROBENZYL)OXY]PHENYL)ACRYLIC ACID

C16H12Cl2O3 (322.0163)


   

3-(4-((3,4-DICHLOROBENZYL)OXY)PHENYL)ACRYLIC ACID

3-(4-((3,4-DICHLOROBENZYL)OXY)PHENYL)ACRYLIC ACID

C16H12Cl2O3 (322.0163)


   

N-[2-butyl-3-[4-(3-butylaMino) propoxy]benzoyl]-5-benzofuranyl] MethanesulfonaMide

N-[2-butyl-3-[4-(3-butylaMino) propoxy]benzoyl]-5-benzofuranyl] MethanesulfonaMide

C12H10N4O3S2 (322.0194)


   

1-(BENZYLOXY)-4-BROMO-2,5-DIMETHOXYBENZENE

1-(BENZYLOXY)-4-BROMO-2,5-DIMETHOXYBENZENE

C15H15BrO3 (322.0204)


   

3-chloro-2-(3-chloro-4-methoxyphenyl)-5-methoxyindazole

3-chloro-2-(3-chloro-4-methoxyphenyl)-5-methoxyindazole

C15H12Cl2N2O2 (322.0276)


   

4,4-CARBONYLBIS(PHTHALIC ANHYDRIDE)

4,4-CARBONYLBIS(PHTHALIC ANHYDRIDE)

C17H6O7 (322.0114)


   

N,N-bis(3-chlorophenyl)propanediamide

N,N-bis(3-chlorophenyl)propanediamide

C15H12Cl2N2O2 (322.0276)


   

robinetinidin chloride

robinetinidin chloride

C15H11ClO6 (322.0244)


   

2-(2-Bromophenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborine

2-(2-Bromophenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborine

C16H12BBrN2 (322.0277)


   

2-(3-Bromophenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborine

2-(3-Bromophenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborine

C16H12BBrN2 (322.0277)


   

2-(4-Bromophenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborine

2-(4-Bromophenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborine

C16H12BBrN2 (322.0277)


   

4-iodo-1-[2-(oxan-2-yloxy)ethyl]pyrazole

4-iodo-1-[2-(oxan-2-yloxy)ethyl]pyrazole

C10H15IN2O2 (322.0178)


   

4-(3-NITRO-BENZENESULFONYLAMINO)-BENZOIC ACID

4-(3-NITRO-BENZENESULFONYLAMINO)-BENZOIC ACID

C13H10N2O6S (322.026)


   

2-Hydroxy-5-[(4-sulfophenyl)diazenyl]benzoic acid

2-Hydroxy-5-[(4-sulfophenyl)diazenyl]benzoic acid

C13H10N2O6S (322.026)


   

2,4,6-tris(trifluoromethyl)-1H-benzimidazole

2,4,6-tris(trifluoromethyl)-1H-benzimidazole

C10H3F9N2 (322.0153)


   

5-[[(7-CHLORO-4-QUINOLINYL)SULFANYL]METHYL]-4-METHYL-4H-1,2,4-TRIAZOLE-3-THIOL

5-[[(7-CHLORO-4-QUINOLINYL)SULFANYL]METHYL]-4-METHYL-4H-1,2,4-TRIAZOLE-3-THIOL

C13H11ClN4S2 (322.0114)


   

4-Iodo-4-propylbiphenyl

4-Iodo-4-propylbiphenyl

C15H15I (322.0218)


   

(5-Chloropyrazolo[1,5-A]pyrimidin-7-YL)-(4-methanesulfonylphenyl)amine

(5-Chloropyrazolo[1,5-A]pyrimidin-7-YL)-(4-methanesulfonylphenyl)amine

C13H11ClN4O2S (322.0291)


   

UMP dianion

UMP dianion

C9H11N2O9P-2 (322.0202)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

L-erythro-Chloramphenicol

L-erythro-Chloramphenicol

C11H12Cl2N2O5 (322.0123)


   

5-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]-4-ethyl-4H-1,2,4-triazole-3-thiol

5-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]-4-ethyl-4H-1,2,4-triazole-3-thiol

C13H11ClN4S2 (322.0114)


   
   

Trofosfamide

Trofosfamide

C9H18Cl3N2O2P (322.0171)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents > L01AA - Nitrogen mustard analogues D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D009676 - Noxae > D000477 - Alkylating Agents D009676 - Noxae > D009153 - Mutagens

   

3-O-phosphonatouridine

3-O-phosphonatouridine

C9H11N2O9P-2 (322.0202)


   

Pseudouridine 5-phosphate(2-)

Pseudouridine 5-phosphate(2-)

C9H11N2O9P-2 (322.0202)


   

Uridine 2-phosphate(2-)

Uridine 2-phosphate(2-)

C9H11N2O9P-2 (322.0202)


   

Arabinouracil 5-monophosphate

Arabinouracil 5-monophosphate

C9H11N2O9P-2 (322.0202)


   

[1-[(3,4-Dichlorophenyl)methyl]-2-hydroxyindol-3-yl]-oxidoazanium

[1-[(3,4-Dichlorophenyl)methyl]-2-hydroxyindol-3-yl]-oxidoazanium

C15H12Cl2N2O2 (322.0276)


   

Merdafos

Sulprofos

C12H19O2PS3 (322.0285)


C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor

   

2,2-dichloro-N-[1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide

2,2-dichloro-N-[1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide

C11H12Cl2N2O5 (322.0123)


   

uridine 5-monophosphate(2-)

uridine 5-monophosphate(2-)

C9H11N2O9P (322.0202)


A pyrimidine nucleoside 5-monophosphate(2-) that results from the removal of two protons from the phosphate group of UMP.

   

3-UMP(2-)

3-UMP(2-)

C9H11N2O9P (322.0202)


A nucleoside 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of uridine 3-monophosphate (UMP). It is the predominant species at physiological pH.

   

Pseudouridine 5-phosphate(2-)

Pseudouridine 5-phosphate(2-)

C9H11N2O9P (322.0202)


An organophosphate oxoanion arising from deprotonation of the phosphate OH groups of pseudouridine 5-phosphate; major species at pH 7.3.

   

(3z,5e,7e,9e,11r)-1,1,1-trichloro-4-hydroxy-11-methyltrideca-3,5,7,9-tetraen-2-one

(3z,5e,7e,9e,11r)-1,1,1-trichloro-4-hydroxy-11-methyltrideca-3,5,7,9-tetraen-2-one

C14H17Cl3O2 (322.0294)


   

1,1,1-trichloro-4-hydroxy-11-methyltrideca-3,5,7,9-tetraen-2-one

1,1,1-trichloro-4-hydroxy-11-methyltrideca-3,5,7,9-tetraen-2-one

C14H17Cl3O2 (322.0294)


   

2-[(dichloromethoxy)methyl]-3-hydroxy-3-(4-nitrophenyl)propanimidic acid

2-[(dichloromethoxy)methyl]-3-hydroxy-3-(4-nitrophenyl)propanimidic acid

C11H12Cl2N2O5 (322.0123)


   

2,2-dichloro-n-[1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]ethanimidic acid

2,2-dichloro-n-[1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]ethanimidic acid

C11H12Cl2N2O5 (322.0123)


   

2,2-dichloro-n-[(1r,2r)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]ethanimidic acid

2,2-dichloro-n-[(1r,2r)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]ethanimidic acid

C11H12Cl2N2O5 (322.0123)


   

(3z,5e,7e,9e)-1,1,1-trichloro-4-hydroxy-11-methyltrideca-3,5,7,9-tetraen-2-one

(3z,5e,7e,9e)-1,1,1-trichloro-4-hydroxy-11-methyltrideca-3,5,7,9-tetraen-2-one

C14H17Cl3O2 (322.0294)